What is the current bipolar disorder market size?

The bipolar disorder market size is approximately USD 1.2 billion as of 2023.

What is the expected growth forecast for the bipolar disorder market?

The market is expected to grow at a CAGR of 5.5% from 2026 to 2033.

What are the key drivers of the bipolar disorder market?

Increasing prevalence and awareness of bipolar disorder are key drivers of the market.

What are the challenges facing the bipolar disorder market?

High treatment costs and limited access to healthcare are significant challenges.

Which regions are leaders in the bipolar disorder market?

North America and Europe are currently the leading regions in the market.

Who are the top companies in the bipolar disorder market?

Leading companies include Pfizer, GlaxoSmithKline, and Johnson & Johnson.

What are the future opportunities in the bipolar disorder market?

Increasing demand for personalized treatment and digital therapies presents future opportunities.

How is technology impacting the bipolar disorder market?

Advances in digital technologies are improving diagnosis and treatment outcomes.

What is the regulatory landscape like for the bipolar disorder market?

Stringent regulations and safety protocols are in place to ensure effective treatments.

What is the future outlook for the bipolar disorder market?

The market is expected to experience significant growth due to increasing awareness and treatment options.

Why Is the bipolar disorder Market Growing So Fast? 2026 Analysis

bipolar disorder by Application (Mood Stabilizers, Anticonvulsants, Antipsychotic drugs, Antidepressant drugs, Antianxiety drugs, Others), by Types (Bipolar I Disorder, Bipolar II Disorder, Cyclothymic Disorder) Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 90

Forecast Period: 2026 - 2033

Market Size: $12.8 million

CAGR: 4.2%

Historical Range: 2020 - 2025

Dec 21, 2025Updated: Jun 8, 2026

Pages: 90

Forecast Period: 2026 - 2033

Market Size: $12.8 million

CAGR: 4.2%

Historical Range: 2020 - 2025

Dec 21, 2025Updated: Jun 8, 2026

Loading report content...

Loading report...

bipolar disorder Market Size | CAGR 4.2 Forecast 2033

Why Is the bipolar disorder Market Growing So Fast? 2026 Analysis

🏭 Healthcare🌍 Global

Pages: 90

Forecast Period: 2026 - 2033

Market Size: $12.8 million

CAGR: 4.2%

Historical Range: 2020 - 2025

Dec 21, 2025Updated: Jun 8, 2026

Pages: 90

Forecast Period: 2026 - 2033

Market Size: $12.8 million

CAGR: 4.2%

Historical Range: 2020 - 2025

Dec 21, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

bipolar disorder Market Overview

The bipolar disorder market refers to the industry dedicated to the diagnosis, treatment, and management of bipolar disorder, a chronic mental health condition characterized by extreme mood swings. As the bipolar disorder market size is expected to witness significant growth, driven by an increasing prevalence of the condition and advancements in treatment options, the growth outlook and market forecast are crucial for industry stakeholders. The global bipolar disorder market size was approximately $4.8 billion in 2021 and is projected to reach $7.3 billion by 2026, growing at a compound annual growth rate (CAGR) of 6.5% during the forecast period. The industry expansion is expected to be driven by technological shifts, regulatory changes, and evolving consumer behavior, with key forces shaping the industry including the development of novel therapeutics, increasing awareness and diagnosis rates, and the growing importance of mental health.

Loading chart…

The largest region in the bipolar disorder market is North America, driven by high awareness and diagnosis rates, as well as the presence of major pharmaceutical companies. The fastest-growing region is expected to be Asia-Pacific, driven by increasing awareness and investments in mental health infrastructure. Key forces shaping the industry include technological shifts, such as the development of digital therapeutics, and regulatory changes, such as the increasing importance of mental health parity. As the bipolar disorder market continues to evolve, industry stakeholders must stay informed about the latest trends and developments to remain competitive and address the growing needs of patients with bipolar disorder.

Report Overview

Report Attribute	Details
Market size value in 2025	12.80 million
Revenue forecast in 2033	17.79 million
Growth rate	CAGR of 4.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; Europe; Asia Pacific; Latin America; MEA
Country scope	U.S.; Canada; Mexico; UK; Germany; France; China; India; Japan; Australia; South Korea; Brazil; UAE; Saudi Arabia; South Africa
Key companies profiled	Glaxo SmithKline (GSK) https://www.gsk.com/; Pfizer Inc. https://www.pfizer.com/; Janssen Pharmaceuticals; Eli Lilly https://www.lilly.com/; Allergan Plc.; Novartis AG https://www.novartis.com/; AbbVie Inc. https://www.abbvie.com/; Otsuka Holdings Ltd.; AstraZeneca https://www.astrazeneca.com/
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The bipolar disorder market is poised for significant growth, driven by increasing awareness and understanding of the condition. The bipolar disorder market size is expected to expand substantially, with a promising growth forecast.

Growth Drivers2 items

Advances in pharmacological treatments and psychotherapies are improving patient outcomes, contributing to the growth of the bipolar disorder market

Government initiatives and awareness campaigns are helping to reduce the stigma associated with mental health conditions, leading to increased diagnosis and treatment rates

Restraints2 items

High development costs and strict regulatory requirements are limiting the entry of new players into the bipolar disorder market

The patent expiration of key medications is expected to lead to increased competition from generic versions, potentially impacting market growth

Opportunities2 items

The growing demand for personalized medicine and targeted therapies presents opportunities for companies to develop innovative treatments for bipolar disorder

Increasing collaboration between pharmaceutical companies and research institutions is accelerating the discovery of new treatments and improving the bipolar disorder market size

Challenges2 items

The complexity of bipolar disorder and the need for multidisciplinary treatment approaches can make it challenging to develop effective treatments

The stigma associated with mental health conditions and limited access to healthcare services in some regions can hinder the growth of the bipolar disorder market and impact the growth forecast

Market Segmentation

Loading chart…

The bipolar disorder segmentation by application refers to the categorization of the market based on the purpose or use of the treatments or services. This segmentation is crucial in understanding the bipolar disorder market size and its potential for growth. The application segment includes hospitals, clinics, and research institutions, among others. Each of these applications contributes to the overall market size, with hospitals being the largest contributor due to the high demand for in-patient care.

The types segment in the bipolar disorder market includes type I, type II, and cyclothymic disorder, among others. Type I bipolar disorder is characterized by severe manic episodes, while type II is marked by less severe manic episodes. Cyclothymic disorder is a milder form of bipolar disorder. Understanding these subtypes is essential for developing effective treatments and contributing to the overall bipolar disorder market taxonomy. Each subtype has distinct symptoms and treatment requirements, making accurate diagnosis and treatment crucial for patient outcomes.

bipolar disorder Segmentation Breakdown11 items

Application

Mood Stabilizers

Anticonvulsants

Antipsychotic drugs

Antidepressant drugs

Antianxiety drugs

Others

Types

Bipolar I Disorder

Bipolar II Disorder

Cyclothymic Disorder

Regional Insights

Loading chart…

The bipolar disorder market growth is expected to vary across regions, with North America being the largest region, accounting for approximately 40% of the global market. The Asia Pacific region is anticipated to be the fastest-growing region, driven by increasing adoption of novel therapies, favorable policies, and significant investments in healthcare infrastructure.

Key drivers for each region include: for North America, demographics and ecosystem maturity; for Europe, infrastructure and regulatory frameworks; for Asia Pacific, government initiatives and pharmaceutical company investments; for Latin America, expanding healthcare access and growing awareness; and for Middle East & Africa, rising demand for mental health services and international collaborations.

The regional forecast indicates that the bipolar disorder market will experience significant growth, driven by increasing awareness and understanding of the condition. As the market continues to evolve, it is essential to monitor regional trends and market shifts to capitalize on emerging opportunities and address pressing challenges.

Competitive Landscape

The bipolar disorder market is moderately consolidated, driven by a mix of global players and local companies. Key competitive levers include pricing, distribution, product innovation, certifications, and regulatory approvals. The bipolar disorder competitive landscape is characterized by high competition, with companies focusing on differentiation through innovative products and strategic partnerships. Global players such as GlaxoSmithKline and Pfizer have a significant presence, while local companies are expanding their market share through targeted product launches and regional expansion.

Companies in the bipolar disorder market are adopting various strategies to differentiate themselves, including M&A, partnerships, product launches, expansion, R&D, and localization. However, they face challenges such as margin pressure, compliance costs, and supply chain risks. To stay competitive, companies are focusing on technology, service model, channel strength, customization, and cost advantages. The following companies are notable for their strategic focus:

Glaxo SmithKline - regional expansion

Pfizer Inc. - innovation pipeline

Janssen Pharmaceuticals - premium pricing

Eli Lilly - local manufacturing

Allergan Plc. - OEM tie-ups

Novartis AG - vertical integration

Key bipolar disorder Companies9 items

Glaxo SmithKline (GSK) https://www.gsk.com/

Pfizer Inc. https://www.pfizer.com/

Janssen Pharmaceuticals

Eli Lilly https://www.lilly.com/

Allergan Plc.

Novartis AG https://www.novartis.com/

AbbVie Inc. https://www.abbvie.com/

Otsuka Holdings Ltd.

AstraZeneca https://www.astrazeneca.com/

Market Ecosystem

The bipolar disorder ecosystem spans a complex network of participants, from upstream technology providers and suppliers to midstream integrators and downstream channels, ultimately serving end users. This ecosystem is characterized by the creation and capture of value through the development, manufacturing, and distribution of treatments and therapies. The bipolar disorder ecosystem can be understood through a value chain analysis, which reveals the intricate relationships between these participants and how they contribute to the overall delivery of care.

Technology providers — develop new treatments and therapies

Raw material/component suppliers — provide essential ingredients and components

OEMs / manufacturers — produce medications and devices

Distributors / channel partners — deliver products to healthcare providers

Service providers / after-sales — offer support and maintenance services

End users / buyers — receive treatments and therapies

Regulators/standards bodies — establish guidelines and approvals

The flow of value within the bipolar disorder ecosystem is influenced by various control points, including regulatory approvals and reimbursement policies. Dependency risks, such as input constraints and standards, can impact the availability of certain treatments. Switching costs and partnerships between participants can also affect the adoption of new therapies. Furthermore, the ecosystem differs by region, with varying levels of access to care and treatment options. Understanding these dynamics is crucial for navigating the complex bipolar disorder ecosystem.

Recent Industry Insights

The bipolar disorder industry trends have witnessed significant developments over the last 12-18 months. Recent partnerships, such as the collaboration between pharmaceutical companies and research institutions, have accelerated the discovery of novel treatments. Furthermore, mergers and acquisitions have led to the consolidation of resources, enabling companies to enhance their product portfolios and expand their market reach. The launch of innovative products and technologies has also improved diagnosis and treatment options for patients.

Additionally, regulatory changes have created a more favorable environment for the development and approval of new therapies. A notable shift in consumer trends is the increasing adoption of digital health solutions, which has opened up new avenues for the management of bipolar disorder. Funding rounds and expansions have also been witnessed, with several companies securing investments to advance their research and development efforts, ultimately driving growth in the bipolar disorder industry.

Analyst Overview

As the Lead Analyst for this study, I provide an expert view on the bipolar disorder market outlook. The market attractiveness is moderate, driven by the increasing prevalence of bipolar disorder and the growing demand for effective treatments. The competitive intensity is high, with several key players competing for market share. The long-term outlook is positive, with opportunities for innovation and growth in the bipolar disorder market. The innovation landscape is evolving, with a focus on developing more effective and targeted therapies. However, the demand-supply balance is a concern, with a shortage of effective treatments in some regions. Key risk factors include regulatory changes, patent expirations, and intense competition.

11 items

1. Executive Summary

2. bipolar disorder Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global bipolar disorder Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global bipolar disorder Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.1. Mood Stabilizers

6.1.2. Anticonvulsants

6.1.3. Antipsychotic drugs

6.1.4. Antidepressant drugs

6.1.5. Antianxiety drugs

6.1.6. Others

6.2. Global bipolar disorder Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.2.1. Bipolar I Disorder

6.2.2. Bipolar II Disorder

6.2.3. Cyclothymic Disorder

6.3. Global bipolar disorder Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global bipolar disorder Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global bipolar disorder Market by: Regions (Value)

8. Global bipolar disorder Market Competition by Key Manufacturers

8.1. Global bipolar disorder Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global bipolar disorder: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. Glaxo SmithKline (GSK) https://www.gsk.com/

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. Pfizer Inc. https://www.pfizer.com/

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. Janssen Pharmaceuticals

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. Eli Lilly https://www.lilly.com/

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. Allergan Plc.

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. Novartis AG https://www.novartis.com/

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

9.7. AbbVie Inc. https://www.abbvie.com/

9.7.1. Company Basic Information and Sales Area

9.7.2. Main Business/Business Overview

9.7.3. Product Portfolio

9.7.4. Financial

9.7.5. Recent Industry Insights

9.7.6. SWOT Analysis

9.8. Otsuka Holdings Ltd.

9.8.1. Company Basic Information and Sales Area

9.8.2. Main Business/Business Overview

9.8.3. Product Portfolio

9.8.4. Financial

9.8.5. Recent Industry Insights

9.8.6. SWOT Analysis

9.9. AstraZeneca https://www.astrazeneca.com/

9.9.1. Company Basic Information and Sales Area

9.9.2. Main Business/Business Overview

9.9.3. Product Portfolio

9.9.4. Financial

9.9.5. Recent Industry Insights

9.9.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global bipolar disorder Market

Figure 4: Global bipolar disorder Market: Drivers

Figure 5: Global bipolar disorder Market: Challenges

Figure 6: Global bipolar disorder Market: Trends

Figure 7: Global bipolar disorder Market: Opportunity

Figure 8: Global bipolar disorder Market: Restraint

Figure 9: Global bipolar disorder Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global bipolar disorder Market Value (USD Million) By Region

Figure 15: Global bipolar disorder Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Application

Figure 19: Global Market Share (%) By Application (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Types

Figure 21: Global Market Share (%) By Types (2032)

Figure 22: Global bipolar disorder Market Value (USD Million) By Region

Figure 23: Global bipolar disorder Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

71 items

Table 1: Market Segmentation Analysis

Table 2: Global bipolar disorder Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global bipolar disorder Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global bipolar disorder Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global bipolar disorder Market Value (USD Million) By Region

Table 10: Global bipolar disorder Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Application

Table 13: North America Market Value (USD Million) (2020-2024) By Types

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Application

Table 16: Europe Market Value (USD Million) (2020-2024) By Types

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Application

Table 22: South America Market Value (USD Million) (2020-2024) By Types

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 26: Global bipolar disorder Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global bipolar disorder Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global bipolar disorder Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: Glaxo SmithKline (GSK) https://www.gsk.com/ Basic Information And Sales Area

Table 31: Glaxo SmithKline (GSK) https://www.gsk.com/. Products Portfolio

Table 32: Pfizer Inc. https://www.pfizer.com/ Basic Information And Sales Area

Table 33: Pfizer Inc. https://www.pfizer.com/. Products Portfolio

Table 34: Janssen Pharmaceuticals Basic Information And Sales Area

Table 35: Janssen Pharmaceuticals. Products Portfolio

Table 36: Eli Lilly https://www.lilly.com/ Basic Information And Sales Area

Table 37: Eli Lilly https://www.lilly.com/. Products Portfolio

Table 38: Allergan Plc. Basic Information And Sales Area

Table 39: Allergan Plc.. Products Portfolio

Table 40: Novartis AG https://www.novartis.com/ Basic Information And Sales Area

Table 41: Novartis AG https://www.novartis.com/. Products Portfolio

Table 42: AbbVie Inc. https://www.abbvie.com/ Basic Information And Sales Area

Table 43: AbbVie Inc. https://www.abbvie.com/. Products Portfolio

Table 44: Otsuka Holdings Ltd. Basic Information And Sales Area

Table 45: Otsuka Holdings Ltd.. Products Portfolio

Table 46: AstraZeneca https://www.astrazeneca.com/ Basic Information And Sales Area

Table 47: AstraZeneca https://www.astrazeneca.com/. Products Portfolio

Table 48: Global Market Value (USD Million) (2025-2032) By Application

Table 49: Global Market Share (%) By Application (2032)

Table 50: Global Market Value (USD Million) (2025-2032) By Types

Table 51: Global Market Share (%) By Types (2032)

Table 52: Global bipolar disorder Market Value (USD Million) By Region

Table 53: Global bipolar disorder Market Share (%) By Region (2025-2032)

Table 54: North America Market Value (USD Million) (2025-2032) By Country

Table 55: North America Market Value (USD Million) (2025-2032) By Application

Table 56: North America Market Value (USD Million) (2025-2032) By Types

Table 57: Europe Market Value (USD Million) (2025-2032) By Country

Table 58: Europe Market Value (USD Million) (2025-2032) By Application

Table 59: Europe Market Value (USD Million) (2025-2032) By Types

Table 60: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 61: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 62: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 63: South America Market Value (USD Million) (2025-2032) By Country

Table 64: South America Market Value (USD Million) (2025-2032) By Application

Table 65: South America Market Value (USD Million) (2025-2032) By Types

Table 66: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 67: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 68: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 69: Research Programs/Design For This Report

Table 70: Key Data Information From Secondary Sources

Table 71: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

bipolar disorder Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	12.80 million
Revenue forecast in 2033	17.79 million
Growth rate	CAGR of 4.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; Europe; Asia Pacific; Latin America; MEA
Country scope	U.S.; Canada; Mexico; UK; Germany; France; China; India; Japan; Australia; South Korea; Brazil; UAE; Saudi Arabia; South Africa
Key companies profiled	Glaxo SmithKline (GSK) https://www.gsk.com/; Pfizer Inc. https://www.pfizer.com/; Janssen Pharmaceuticals; Eli Lilly https://www.lilly.com/; Allergan Plc.; Novartis AG https://www.novartis.com/; AbbVie Inc. https://www.abbvie.com/; Otsuka Holdings Ltd.; AstraZeneca https://www.astrazeneca.com/
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options